Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Valves | 7 | 2013 | 171 | 1.480 |
Why?
|
| Myocytes, Cardiac | 7 | 2011 | 442 | 0.960 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2012 | 144 | 0.760 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2010 | 328 | 0.640 |
Why?
|
| Foreign-Body Reaction | 2 | 2018 | 24 | 0.640 |
Why?
|
| Prostheses and Implants | 2 | 2018 | 159 | 0.590 |
Why?
|
| Vascular Diseases | 1 | 2017 | 94 | 0.560 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 236 | 0.560 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2007 | 27 | 0.550 |
Why?
|
| Mitosis | 2 | 2007 | 76 | 0.530 |
Why?
|
| Models, Theoretical | 1 | 2017 | 384 | 0.470 |
Why?
|
| Cell Adhesion Molecules | 3 | 2009 | 199 | 0.440 |
Why?
|
| Chickens | 3 | 2010 | 232 | 0.440 |
Why?
|
| Chick Embryo | 9 | 2013 | 379 | 0.430 |
Why?
|
| Avian Proteins | 1 | 2012 | 23 | 0.430 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 37 | 0.430 |
Why?
|
| Animals | 32 | 2018 | 20881 | 0.410 |
Why?
|
| Collagen | 4 | 2018 | 636 | 0.400 |
Why?
|
| Heart | 6 | 2011 | 850 | 0.380 |
Why?
|
| Multiple Myeloma | 2 | 2022 | 92 | 0.380 |
Why?
|
| Collagen Type I | 7 | 2018 | 175 | 0.340 |
Why?
|
| Fibroblasts | 2 | 2017 | 902 | 0.340 |
Why?
|
| Cell Lineage | 2 | 2009 | 146 | 0.330 |
Why?
|
| Myocardium | 2 | 2007 | 1204 | 0.330 |
Why?
|
| Coronary Vessels | 2 | 2009 | 313 | 0.330 |
Why?
|
| Rats | 16 | 2018 | 5300 | 0.330 |
Why?
|
| Tissue Engineering | 5 | 2017 | 212 | 0.320 |
Why?
|
| Cell Cycle | 2 | 2007 | 312 | 0.320 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 230 | 0.310 |
Why?
|
| Mesoderm | 1 | 2009 | 231 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 219 | 0.300 |
Why?
|
| Hydrogels | 2 | 2018 | 54 | 0.300 |
Why?
|
| alpha 1-Antitrypsin | 3 | 1997 | 61 | 0.300 |
Why?
|
| Hyperplasia | 1 | 2007 | 89 | 0.290 |
Why?
|
| Microscopy, Confocal | 7 | 2012 | 337 | 0.290 |
Why?
|
| Pericardium | 4 | 2009 | 97 | 0.280 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 371 | 0.280 |
Why?
|
| Evolution, Molecular | 2 | 1997 | 79 | 0.270 |
Why?
|
| Cardiomegaly | 1 | 2007 | 213 | 0.270 |
Why?
|
| Cell Culture Techniques | 4 | 2010 | 189 | 0.260 |
Why?
|
| Bone Marrow Cells | 4 | 2011 | 217 | 0.250 |
Why?
|
| Models, Biological | 2 | 2008 | 981 | 0.250 |
Why?
|
| Microfilament Proteins | 3 | 2012 | 102 | 0.230 |
Why?
|
| Cell Differentiation | 9 | 2013 | 1034 | 0.230 |
Why?
|
| Neovascularization, Physiologic | 3 | 2010 | 164 | 0.230 |
Why?
|
| Biocompatible Materials | 3 | 2014 | 247 | 0.220 |
Why?
|
| Breast Implants | 2 | 2014 | 18 | 0.200 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 5 | 0.200 |
Why?
|
| Stromal Cells | 4 | 2011 | 113 | 0.200 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 74 | 0.200 |
Why?
|
| Endothelial Cells | 3 | 2017 | 384 | 0.190 |
Why?
|
| Mice | 11 | 2012 | 8474 | 0.190 |
Why?
|
| Muridae | 3 | 1997 | 9 | 0.190 |
Why?
|
| Anatomy | 1 | 2021 | 36 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 1293 | 0.180 |
Why?
|
| Minority Groups | 1 | 2022 | 197 | 0.180 |
Why?
|
| Cells, Cultured | 5 | 2009 | 2673 | 0.180 |
Why?
|
| Students | 1 | 2022 | 233 | 0.180 |
Why?
|
| Blotting, Western | 3 | 2012 | 954 | 0.170 |
Why?
|
| Regeneration | 2 | 2010 | 105 | 0.170 |
Why?
|
| Students, Medical | 1 | 2021 | 210 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2017 | 144 | 0.160 |
Why?
|
| Extracellular Matrix | 2 | 2012 | 493 | 0.160 |
Why?
|
| Compressive Strength | 1 | 2018 | 17 | 0.150 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2011 | 127 | 0.150 |
Why?
|
| Cell Communication | 1 | 2017 | 116 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2018 | 2083 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2008 | 152 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 234 | 0.140 |
Why?
|
| Mammals | 1 | 1996 | 47 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 710 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2018 | 546 | 0.130 |
Why?
|
| Microscopy, Atomic Force | 2 | 2012 | 66 | 0.130 |
Why?
|
| Implant Capsular Contracture | 1 | 2014 | 2 | 0.120 |
Why?
|
| Silicones | 2 | 2018 | 32 | 0.120 |
Why?
|
| Cell Movement | 3 | 2013 | 630 | 0.120 |
Why?
|
| Absorbable Implants | 1 | 2014 | 29 | 0.120 |
Why?
|
| Quail | 3 | 2009 | 27 | 0.120 |
Why?
|
| Cell Division | 2 | 2007 | 541 | 0.120 |
Why?
|
| Immunohistochemistry | 5 | 2010 | 1174 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 83 | 0.110 |
Why?
|
| Zyxin | 1 | 2013 | 3 | 0.110 |
Why?
|
| Elastin | 1 | 2014 | 116 | 0.110 |
Why?
|
| Tenascin | 1 | 2012 | 39 | 0.110 |
Why?
|
| Aorta | 1 | 2014 | 316 | 0.110 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2012 | 27 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2012 | 32 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 62 | 0.110 |
Why?
|
| Morphogenesis | 2 | 2013 | 159 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2012 | 84 | 0.100 |
Why?
|
| Myxoma | 1 | 2012 | 17 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2012 | 17 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 24 | 0.100 |
Why?
|
| Amides | 1 | 2012 | 86 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 208 | 0.100 |
Why?
|
| Mitral Valve Prolapse | 1 | 2012 | 40 | 0.100 |
Why?
|
| Embryonic Development | 3 | 2011 | 100 | 0.100 |
Why?
|
| RNA, Messenger | 6 | 2010 | 1664 | 0.100 |
Why?
|
| Heart Ventricles | 2 | 2009 | 738 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2011 | 31 | 0.100 |
Why?
|
| Lysophospholipids | 1 | 2012 | 209 | 0.100 |
Why?
|
| Mitral Valve | 1 | 2012 | 166 | 0.100 |
Why?
|
| Stem Cells | 2 | 2010 | 248 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 88 | 0.090 |
Why?
|
| Pyridines | 1 | 2012 | 261 | 0.090 |
Why?
|
| Stilbenes | 1 | 2011 | 57 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 770 | 0.090 |
Why?
|
| Fetal Diseases | 1 | 2011 | 64 | 0.090 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2010 | 12 | 0.090 |
Why?
|
| Species Specificity | 4 | 2006 | 303 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 498 | 0.090 |
Why?
|
| Cell Transplantation | 1 | 2010 | 22 | 0.090 |
Why?
|
| Pregnancy in Diabetics | 1 | 2011 | 70 | 0.090 |
Why?
|
| Tissue Scaffolds | 2 | 2008 | 111 | 0.090 |
Why?
|
| Base Sequence | 4 | 2010 | 1015 | 0.090 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2009 | 16 | 0.080 |
Why?
|
| Lipids | 1 | 2011 | 298 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 32 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 133 | 0.080 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 122 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 123 | 0.080 |
Why?
|
| Connexin 43 | 1 | 2009 | 62 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2009 | 87 | 0.080 |
Why?
|
| Heart Atria | 1 | 2009 | 206 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 246 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 268 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 333 | 0.080 |
Why?
|
| Atrioventricular Node | 1 | 2008 | 39 | 0.080 |
Why?
|
| Humans | 10 | 2022 | 68618 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2011 | 631 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2007 | 3 | 0.070 |
Why?
|
| G2 Phase | 1 | 2007 | 26 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2008 | 99 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2007 | 61 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 596 | 0.070 |
Why?
|
| Intracellular Space | 1 | 2007 | 42 | 0.070 |
Why?
|
| Wound Healing | 1 | 2009 | 260 | 0.070 |
Why?
|
| Fibrillar Collagens | 1 | 2007 | 49 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2007 | 89 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 396 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 62 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 159 | 0.070 |
Why?
|
| Time Factors | 2 | 2012 | 4655 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 483 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2011 | 718 | 0.070 |
Why?
|
| Genes | 2 | 1997 | 86 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 322 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 1997 | 251 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 396 | 0.070 |
Why?
|
| DNA Replication | 1 | 2007 | 167 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2006 | 324 | 0.070 |
Why?
|
| Mice, Inbred ICR | 1 | 2005 | 44 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 1997 | 1447 | 0.060 |
Why?
|
| Pregnancy | 3 | 2011 | 2334 | 0.060 |
Why?
|
| Algorithms | 1 | 2011 | 1196 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1174 | 0.060 |
Why?
|
| Apoptosis | 1 | 2011 | 1641 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2005 | 447 | 0.060 |
Why?
|
| Cattle | 2 | 2018 | 475 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2008 | 236 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2003 | 37 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 351 | 0.050 |
Why?
|
| Protective Factors | 1 | 2022 | 24 | 0.050 |
Why?
|
| Bortezomib | 1 | 2022 | 45 | 0.050 |
Why?
|
| Plasma Cells | 1 | 2022 | 19 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2022 | 168 | 0.050 |
Why?
|
| Career Choice | 1 | 2022 | 98 | 0.050 |
Why?
|
| Perception | 1 | 2022 | 189 | 0.050 |
Why?
|
| Research | 1 | 2022 | 214 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1692 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 213 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1851 | 0.050 |
Why?
|
| Autophagy | 1 | 2022 | 208 | 0.040 |
Why?
|
| Biomechanical Phenomena | 2 | 2014 | 368 | 0.040 |
Why?
|
| Male | 8 | 2022 | 37321 | 0.040 |
Why?
|
| Immunophenotyping | 2 | 2011 | 110 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2011 | 147 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2011 | 489 | 0.040 |
Why?
|
| Culture Media | 2 | 2010 | 155 | 0.040 |
Why?
|
| Female | 6 | 2022 | 38074 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 1593 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 1996 | 165 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 352 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2007 | 2689 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 575 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2008 | 371 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 1997 | 181 | 0.040 |
Why?
|
| Mutation | 2 | 2007 | 1213 | 0.040 |
Why?
|
| Artiodactyla | 1 | 1996 | 2 | 0.030 |
Why?
|
| Primates | 1 | 1996 | 14 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 95 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1996 | 124 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 1996 | 49 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1996 | 207 | 0.030 |
Why?
|
| Calcium | 2 | 2011 | 929 | 0.030 |
Why?
|
| Phylogeny | 1 | 1996 | 197 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1996 | 362 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 532 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2014 | 25 | 0.030 |
Why?
|
| Neural Crest | 1 | 2014 | 58 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 103 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1994 | 71 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 866 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2014 | 113 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1994 | 86 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1994 | 220 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 137 | 0.030 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Filamins | 1 | 2012 | 17 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 51 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2012 | 67 | 0.030 |
Why?
|
| Serotonin | 1 | 2012 | 144 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1033 | 0.020 |
Why?
|
| Interferometry | 1 | 2011 | 6 | 0.020 |
Why?
|
| Onions | 1 | 2011 | 4 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2012 | 231 | 0.020 |
Why?
|
| Lentivirus | 1 | 2011 | 35 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 94 | 0.020 |
Why?
|
| Caspases | 1 | 2011 | 194 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 312 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 49 | 0.020 |
Why?
|
| Equipment Design | 1 | 2011 | 500 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 302 | 0.020 |
Why?
|
| Connexins | 1 | 2009 | 35 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 791 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 343 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 67 | 0.020 |
Why?
|
| Aging | 1 | 2014 | 911 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2008 | 31 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 71 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2007 | 27 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 132 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 200 | 0.020 |
Why?
|
| Myosins | 1 | 2006 | 34 | 0.020 |
Why?
|
| Keratins | 1 | 2006 | 48 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2007 | 295 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 282 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2008 | 343 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7029 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1753 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 947 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 765 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 389 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 1027 | 0.010 |
Why?
|
| Skin | 1 | 2007 | 451 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 65 | 0.010 |
Why?
|
| Child | 1 | 2014 | 6405 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 1752 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2550 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 5717 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 14862 | 0.010 |
Why?
|
| DNA Probes | 1 | 1994 | 57 | 0.010 |
Why?
|
| Gene Library | 1 | 1994 | 68 | 0.010 |
Why?
|
| Multigene Family | 1 | 1994 | 93 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 357 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1994 | 208 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 21403 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 1083 | 0.010 |
Why?
|